<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Morphology</journal-id><journal-title-group><journal-title xml:lang="en">Morphology</journal-title><trans-title-group xml:lang="ru"><trans-title>Морфология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1026-3543</issn><issn publication-format="electronic">2949-2556</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">399345</article-id><article-id pub-id-type="doi">10.17816/morph.399345</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">SEX HORMONES RECEPTOR EXPRESSION AND THE ACTIVITY OF THE ARGYROPHILIC PROTEINS OF THE NUCLEOLAR ORGANIZER REGION IN THE CELLS OF INTACT MYOMETRIUM AND IN LEIOMYOMATA OF THE UTERINE CORPUS</article-title><trans-title-group xml:lang="ru"><trans-title>ЭКСПРЕССИЯ РЕЦЕПТОРОВ ПОЛОВЫХ ГОРМОНОВ И АКТИВНОСТЬ АРГИРОФИЛЬНЫХ БЕЛКОВ ОБЛАСТИ ЯДРЫШКОВЫХ ОРГАНИЗАТОРОВ В КЛЕТКАХ НЕИЗМЕНЕННОГО МИОМЕТРИЯ И ЛЕЙОМИОМЕ ТЕЛА МАТКИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Avdalyan</surname><given-names>A M</given-names></name><name xml:lang="ru"><surname>Авдалян</surname><given-names>А М</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лаборатория молекулярной диагностики (зав. - канд. мед. наук А.М. Авдалян); Алтайский филиал Российского онкологического научного центра им. Н.Н. Блохина РАМН</p></bio><email>ashot_avdalyan@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bobrov</surname><given-names>I P</given-names></name><name xml:lang="ru"><surname>Бобров</surname><given-names>И П</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лаборатория молекулярной диагностики (зав. - канд. мед. наук А.М. Авдалян); Алтайский филиал Российского онкологического научного центра им. Н.Н. Блохина РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Klimachev²</surname><given-names>V V</given-names></name><name xml:lang="ru"><surname>Климачев²</surname><given-names>В В</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра патологической анатомии (зав. - проф. В.В. Климачев); Алтайский государственный медицинский университет</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lazarev</surname><given-names>A F</given-names></name><name xml:lang="ru"><surname>Лазарев</surname><given-names>А Ф</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лаборатория молекулярной диагностики (зав. - канд. мед. наук А.М. Авдалян); Алтайский филиал Российского онкологического научного центра им. Н.Н. Блохина РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Avdalyan</surname><given-names>A M</given-names></name><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name><surname>Bobrov</surname><given-names>I P</given-names></name><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name><surname>Klimachyov</surname><given-names>V V</given-names></name><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name><surname>Lazarev</surname><given-names>A F</given-names></name><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Алтайский филиал Российского онкологического научного центра им. Н.Н. Блохина РАМН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Алтайский государственный медицинский университет</institution></aff></aff-alternatives><aff id="aff3"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2010-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2010</year></pub-date><volume>137</volume><issue>2</issue><issue-title xml:lang="en">NO2 (2010)</issue-title><issue-title xml:lang="ru">№2 (2010)</issue-title><fpage>61</fpage><lpage>65</lpage><history><date date-type="received" iso-8601-date="2023-05-09"><day>09</day><month>05</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, Эко-Вектор</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://j-morphology.com/1026-3543/article/view/399345">https://j-morphology.com/1026-3543/article/view/399345</self-uri><abstract xml:lang="en"><p>The authors have analyzed the expression of progesterone receptor (PR) and estrogen receptor α (ER) in comparison with the argyrophil proteins content in the nucleolar organizer region (NOR) in 106 samples of the intact myometrium and in 106 tumourous nodes of the simple leiomyoma. PR expression was shown in 100% cases of the intact myometrium and simple leiomyoma, while ER expression was far less common, 37.±4.2 and 23.5±4.1%, respectively. There were much fewer AgNOR proteins in the intact myometrium than in the leiomyoma (3.1±0.5 and 5.6±0.4, respectively). Moreover, the number of AgNOR proteins was shown to depend on the presence of ER: when smooth muscle cells were ER-positive, there were fewer argyrophilic granules than when they were absent in both intact myometrium and simple leiomyoma.</p></abstract><trans-abstract xml:lang="ru"><p>На материале 106 образцов неизмененного миометрия и 106 опухолевых узлов простой лейомиомы проведен анализ экспрессии рецепторов прогестерона и эстрогена α (РП и РЭ) в сопоставлении с количеством аргирофильных белков области ядрышковых организаторов (Ag-ОЯОР). Показано, что в неизмененном миометрии и простой лейомиоме РП экспрессировались в 100% случаев, а РЭ значительно реже (37±4 и 24±4% соответственно). Ag-ОЯОР-белков в неизмененном миометрии было значимо меньше, чем в лейомиоме (3,1±0,5 и 5,6±0,4 соответственно). Кроме того, выявлено, что количество Ag-ОЯОР-белков зависело от наличия РЭ. При наличии РЭ как в неизмененном миометрии, так и в лейомиоме, количество аргирофильных гранул было меньше, чем при отсутствии РЭ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>myometrium</kwd><kwd>leiomyoma</kwd><kwd>progesterone receptors</kwd><kwd>estrogen receptors</kwd><kwd>argyrophilic proteins</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>миометрий</kwd><kwd>лейомиома</kwd><kwd>рецепторы прогестерона</kwd><kwd>рецепторы эстрогена</kwd><kwd>аргирофильные белки</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Вихляева Е.М. Руководство по диагностике и лечению лейомиомы матки. М., МЕД пресс-информ, 2004.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Имянитов Е.Н. и Хансон К.П. Молекулярная онкология: клинические аспекты. СПб., Изд. дом СПбМАПО, 2007.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Мамаев Н.Н., Мамаева С.Е., Либуркина И.Л. и др. Активность ядрышковых организаторов нормальных и лейкозных клеток костного мозга человека. Цитология, 1984, т. 26, № 1, с. 46-51.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Савицкий Г.А. и Савицкий А.Г. Миома матки (проблемы патогенеза и патогенетической терапии). СПб., ЭЛБИ, 2000.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Сидорова И.С., Леваков С.А., Зайратьянц О.В. и др. Миома матки (современные проблемы этиологии, патогенеза, диагностики и лечения). М., изд. МИА, 2002.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Aubele M., Bieterferd S., Derenzini M. et al. Guidelines of AgNOR quantitation. Zbl. Pathol., 1994, v. 140, № 1, р. 107- 108.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bakas P., Liapis A., Vlahopoulos S. et al. Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness. Fertil. Steril., 2008, v. 90, № 5, p. 1878-1885.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Derenzini M. The AgNORs. Micron, 2000, v. 31, р. 117-120.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Englund K., Blanck A., Gustavsson I. et al. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J. Clin. Endocrinol. Metabol., 1998, v. 83, № 11, p. 4092-4096.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>ER/PR pharmDx. Targeted therapies require targeted diagnostics. DAKO, Denmark, 2004.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Esposito N.N., Hunt J.L., Bakker A. and Jones M.W. Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors. Am. J. Surg. Pathol., 2006, v. 30, № 1, р. 97-103.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gao Z., Matsuo H., Nakago S. et al. p53 Tumor suppressor protein content in human uterine leiomyomas and its downregulation by 17β-estradiol. J. Clin. Endocrinol. Metabol., 2002, v. 87, № 8, p. 3915-3920.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Jakimiuk A.J., Bogusiewicz M., Tarkowski R. et al. Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil. Steril., 2004, v. 82, № 3, p. 1244-1249.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kelley T.W., Borden E.C. and Goldblum J.R. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study. Appl. Immunohistochem. Mol. Morphol., 2004, v. 12, № 4, p. 338- 341.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Leibsohn S., Ablaing G., Michell D.R. and Schaerth J.B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am. J. Obstet. Gynecol., 1990, v. 162, № 4, p. 968-974.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Maruo T., Ohara N., Wang J. and Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum. Repod. Update, 2004, v. 10, № 3, p. 207-220.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Molinari A.M., Bontempo P., Schiavone E.M. et al. Estradiol induces functional inactivation of p53 by intracellular restibution. Cancer Res., 2000, v. 60, p. 2594-2597.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Ofner D. and Schmid K. W. Standardized AgNOR analysis: its usefulness in surgical oncology. Histochem. Cell Biol., 1996, v. 106, № 2, р. 193-196.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ploton D., Ménager M., Jeannesson P. et al. Improvement in the staining and visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem. J., 1986, v. 18, № 1, р. 5-14.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Shimomura Y., Matsuo H., Samoto T. and Maruo T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J. Clin. Endocrinol. Metabol., 1998, v. 83, № 6, p. 2192-2198.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Viville B., Charnock-Jones D.S., Sharkey A.M. et al. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium. Hum. Reprod., 1997, v. 12, № 4, p. 815-822.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Wu X., Blanck A., Olovsson M. et al. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause. Acta Obstet. Gynecol. Scand., 2000, v. 79, № 5, p. 397-404.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Xu Q., Takekida S., Ohara N. et al. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(ADP-ribose) polymerase expression in cultured human uterine leiomyoma cells. J. Clin. Endocrinol. Metabol., 2004, v. 82, № 5, p. 1936-1940.</mixed-citation></ref></ref-list></back></article>
